After RIPCORD 2, FAME 3, FLOWER-MI and FUTURE: Has the Pressure Wire had its Day?
- PMID: 39081828
- PMCID: PMC11287625
- DOI: 10.15420/icr.2023.17
After RIPCORD 2, FAME 3, FLOWER-MI and FUTURE: Has the Pressure Wire had its Day?
Abstract
Recent years have seen the publication of several high-profile, negative trials about pressure wires. This has coincided with a consistent increase in the ratio of angioplasty for acute coronary syndromes versus percutaneous coronary intervention in stable coronary artery disease, a greater use of intracoronary imaging during percutaneous coronary intervention and the continued evolution of computational fluid dynamics-derived estimations of fractional flow reserve from both CT and invasive coronary angiography. Consequently, many interventional cardiologists now wonder if the pressure wire will soon become obsolete. This head-to-head article provides a critical appraisal of recent trial data, discusses a potential evolution in how pressure wires are used and debates the motion that the device (and by extension, invasive assessment of coronary physiology) has now had its day.
Keywords: Physiology; fractional flow reserve; ischaemia; percutaneous coronary intervention.
Copyright © The Author(s), 2024. Published by Radcliffe Group Ltd.
Conflict of interest statement
Disclosure: BM has received speaker/consultancy fees from Boston Scientific, Chiesi and Sanofi. DC has received speaker/consultancy fees from Abbott. All other authors have no conflicts of interest to declare. Authors’ contributions: Introduction: Ioannis Lampadakis, Sayan Sen; For: Bhavik Modi, Subhabrata Dutta; Against: Damien Collison
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
